Retatrutide, from Soma Pharmaceuticals , is attracting considerable attention as check here a novel method for metabolic regulation. This dual-action compound merges the mechanism of a GLP-1 receptor agonist and a GIP receptor activator , aiming to simply promote weight loss but also improve related metabolic conditions . Preliminary human studies